This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahadevan, V. Articles by Lewis, G. P. Search for Related Content PubMed PubMed Citation Articles by Mahadevan, V. Articles by Lewis, G. P.

Factors Influencing Blood Supply in Wound Granuloma Quantitated by a New in Vivo Technique

Department of Pharmacology, Royal College of Surgeons of England, 35–43 Lincoln's Inn Fields, London WC2A 3PN [V. M., G. P. L.], and Biology of Metastasis Laboratory, Room 536, Imperial Cancer Research Fund, P. O. Box 123, Lincoln's Inn Fields, London WC2A 3PX [V. M., I. R. H.], United Kingdom

A new quantitative assay for measuring angiogenesis in a s.c. located sponge implant in rats is described. Using this model, which detects neovascularization by measuring alterations in ¹³³Xe clearance, it has been shown that the known angiogenic factors, transforming growth factor and tumor necrosis factor , cause maximum vascularization of the sponge to occur by Day 11 postimplantation compared with Days 15 to 17 in control animals. The monokine interleukin 1 is shown to be strongly angiogenic, suggesting that more than one macrophage-derived cytokine may be the active mediator in macrophage-induced angiogenesis. Extracellular matrix proteins appear to play a role in regulating the angiogenic response such that presoaking sponges in laminin (40 µg/ml) or fibrinogen (500 µg/ml) solutions induced a significant reduction in the time taken to achieve maximum ¹³³Xe clearance values; no such enhancement of neovascularization was observed when sponges were presoaked in type IV collagen (100 µg/ml) solution. The assay described here, which is reproducible, objective, and quantitative, should be of considerable use in elucidating the molecular basis of angiogenesis regulation.

¹ To whom requests for reprints should be addressed.

Received 6/ 7/88. Revised 9/30/88. Accepted 10/11/88.

This article has been cited by other articles:

				L. S. Barcelos, A. Talvani, A. S. Teixeira, L. Q. Vieira, G. D. Cassali, S. P. Andrade, and M. M. Teixeira Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1 J. Leukoc. Biol., August 1, 2005; 78(2): 352 - 358. [Abstract] [Full Text] [PDF]

				R. MORI, T. KONDO, T. OHSHIMA, Y. ISHIDA, and N. MUKAIDA Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration FASEB J, July 1, 2002; 16(9): 963 - 974. [Abstract] [Full Text] [PDF]

				K. D. Miller, C. J. Sweeney, and G. W. Sledge Jr Redefining the Target: Chemotherapeutics as Antiangiogenics J. Clin. Oncol., February 15, 2001; 19(4): 1195 - 1206. [Abstract] [Full Text] [PDF]

				A. W. Griffioen and G. Molema Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Pharmacol. Rev., June 1, 2000; 52(2): 237 - 268. [Abstract] [Full Text] [PDF]